Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127660531 | 12766053 | 1 | I | 20160915 | 20160921 | 20160921 | EXP | US-MLMSERVICE-20160909-0419529-1 | US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK024336 | GLENMARK | SHARON N, CULLEN C, MARTINEZ K.. A COMPLEX PRESENTATION OF PEDIATRIC NEUROLEPTIC MALIGNANT SYNDROME RELATED TO POLYPHARMACY IN A 12-YEAR-OLD MALE.. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY.. 2015;26(6):571-573 | 0.00 | Y | 0.00000 | 20160921 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127660531 | 12766053 | 1 | PS | PRAMIPEXOLE DIHYDROCHLORIDE. | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Unknown | 0.125 MG, AT BEDTIME | 90781 | .125 | MG | ||||||||
127660531 | 12766053 | 2 | SS | METHYLPHENIDATE ER | METHYLPHENIDATE | 1 | Unknown | 36 MG, ONCE IN MORNING | 0 | 36 | MG | ||||||||
127660531 | 12766053 | 3 | SS | PAROXETINE. | PAROXETINE | 1 | Unknown | 40 MG, ONCE IN THE MORNING | 0 | 40 | MG | ||||||||
127660531 | 12766053 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.5 MG, BID | 0 | .5 | MG | BID | |||||||
127660531 | 12766053 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.5 MG, QD | 0 | .5 | MG | ||||||||
127660531 | 12766053 | 6 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 1 MG, QD AT BEDTIME | 0 | 1 | MG | ||||||||
127660531 | 12766053 | 7 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 375 MG, QD IN THE MORNING | 0 | 375 | MG | ||||||||
127660531 | 12766053 | 8 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 500 MG, AT BEDTIME | 0 | 500 | MG | ||||||||
127660531 | 12766053 | 9 | C | MELATONIN | MELATONIN | 1 | Unknown | 5 MG, AT BEDTIME AS NEEDED FOR SLEEP | 0 | 5 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127660531 | 12766053 | 1 | Product used for unknown indication |
127660531 | 12766053 | 2 | Product used for unknown indication |
127660531 | 12766053 | 3 | Product used for unknown indication |
127660531 | 12766053 | 4 | Product used for unknown indication |
127660531 | 12766053 | 7 | Product used for unknown indication |
127660531 | 12766053 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127660531 | 12766053 | HO |
127660531 | 12766053 | LT |
127660531 | 12766053 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127660531 | 12766053 | Neuroleptic malignant syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |